This study is in progress, not accepting new patients
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Clark Rosen, MD (ucsf)
Description
Summary
Keywords
Eligibility
Location
Lead Scientist at University of California Health
- Clark Rosen, MD (ucsf)
Clark Rosen, MD is a Director of the UCSF Voice and Swallowing Center, Chief of the Division of Laryngology, Professor of Otolaryngology-Head and Neck Surgery. Dr. Rosen is originally from Los Gatos, California and is a proud graduate of Cal (Go Bears!).
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT05158166
- Phase
- Phase 1/2 Spasmodic Dysphonia Research Study
- Study Type
- Interventional
- Participants
- Expecting 20 study participants
- Last Updated